Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
- Jubilant Ingrevia Ltd reported Revenues for Q2FY24 of ₹1,020.00 Crores down from ₹1,304.00 Crore year on year, a fall of 21.78%.
- Total Expenses for Q2FY24 of ₹949.00 Crores down from ₹1,187.00 Crores year on year, a fall of 20.05%.
- Consolidated Net Profit of ₹57.00 Crores down 32.14% from ₹84.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹3.61, down 31.76% from ₹5.29 in the same quarter of the previous year.